Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

1 Nov 2018

Abstract excerpt

BACKGROUND: Middle East respiratory syndrome (MERS) is caused by MERS coronavirus (MERS-CoV). Thus far, MERS outbreaks have been reported from Saudi Arabia (2013 and 2014) and South Korea (2015). No specific vaccine has yet been reported against MERS. PURPOSE: To address the urgent need for an MERS vaccine, in the present study, we have designed two multi-epitope vaccines (MEVs) against MERS utilizing several in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diverse Scientific Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30538505
DOI: 10.2147/idr.s175114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approachPMID 30538505Read ↗

Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2Semantic proximity Read ↗

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology ApproachSemantic proximity Read ↗

Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approachesSemantic proximity Read ↗

Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approachSemantic proximity Read ↗

Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamicsSemantic proximity Read ↗

Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human healthSemantic proximity Read ↗

In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analysesSemantic proximity Read ↗

Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysisSemantic proximity Read ↗

Analysis of the Genome Sequence and Prediction of B-Cell Epitopes of the Envelope Protein of Middle East Respiratory Syndrome-CoronavirusSemantic proximity Read ↗

In Silico Prediction of a Novel Universal Multi-epitope Peptide Vaccine in the Whole Spike Glycoprotein of MERS CoVSemantic proximity Read ↗

Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and <i>in silico</i> approachesSemantic proximity Read ↗

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.